Metraipolis › archive › dc_6f2bd99c250f

Bridging practices prior to brexucabtagene autoleucel for mantle cell lymphoma in the United Kingdom: An analysis of modality, response, toxicity and survival — Europe PMC PMID:41796018

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41796018
DOI
10.1111/bjh.70357
License (as archived)
solo-consultazione
Archived
2026-11-05T00:38:54.124Z
SHA-256 of the archived text
2b76e899a2d6bfeefab73976426c8ac2a8ffa92ac3e54f618de2e6ed727f818f
Stable URL of this page
https://metraipolis.com/documento/dc_6f2bd99c250f

How to cite

Bridging practices prior to brexucabtagene autoleucel for mantle cell lymphoma in the United Kingdom: An analysis of modality, response, toxicity and survival — Europe PMC PMID:41796018 — Europe PMC (en), https://europepmc.org/article/MED/41796018 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6f2bd99c250f (Metraipolis archive dc_6f2bd99c250f, sha256 2b76e899a2d6bfeefab73976426c8ac2a8ffa92ac3e54f618de2e6ed727f818f)
BibTeX
@misc{dc6f2bd99c250f,
  title = {Bridging practices prior to brexucabtagene autoleucel for mantle cell lymphoma in the United Kingdom: An analysis of modality, response, toxicity and survival — Europe PMC PMID:41796018},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41796018},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6f2bd99c250f; sha256 2b76e899a2d6bfeefab73976426c8ac2a8ffa92ac3e54f618de2e6ed727f818f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41796018. Agents can read the archived copy with the MCP tool read_document.